We take care of the development of immunoassays (competitive, sandwich or indirect assays) using your components.

It contains the following services, which can be used seperatly, too:

  • Synthesis of immunoconjugates for low-molecular agents
  • Preparation and purification of antibodies
  • Preparation of suitable detection conjugates
  • Assay-dimension: microtiter plate, lateral flow, beads or biochip
  • Application of streptavidin-coated plates or biochips is possible
  • Assay-Validation
  • Customer service and troubleshooting

Link to our Therapeutic Drug Monitoring / Companion Diagnostic solutions: recoveryELISA

Moreover, we take care of development of DNA-assays for specific detection of PCR-products or for SNP-analysis.

BioTeZ GmbH

Die BioTeZ Berlin-Buch GmbH ist ein Biotechnologie-Unternehmen und wurde 1992 gegründet. BioTeZ ist Partner der Forschung, der Pharmaindustrie und der Labordiagnostik.

  • Biodiagnostika
  • Oligonukleotide
  • Markierte Biomoleküle

Contact

BioTeZ Berlin Buch GmbH
Robert-Rössle-Strasse 10, Haus D 72
13125 Berlin - Germany

Tel: +49 30-9489-2130
Fax: +49 30-9494-509
E-Mail: info@biotez.de
www.biotez.de

Events

MedicaMeet BioTeZ at MEDICA, 12-15 Nov. 2018, Düsseldorf. 


10th Potsdam Days on Bioanalysis (1./2. November 2018), Potsdam; 
Dr. Janko Brand will give insights in the development projects: recoveryELISA Alirocumab, Evolocumab and PCSK9


SWISS BIOTECH DAY 2018 (3 May 2018, Basel)   Swiss_Biotech_Day
Get Information about diagnostics and biotechnological services we offer: Therapeutic Drug Monitoring, Mycotoxin and Vitamin Analysis, Individual Conjugates, ELISA Development, Oligonucleotides, Human Proteases Research, Streptavidin Coatings, Immobilization Technologies; BioTeZ will summarize outcomes of therapeutic drug monitoring studies with Omalizumab/IgE, Adalimumab/TNF and provide insights into Alirocumab, Evolocumab/PCSK9 recoveryELISA Projects.


Deutsche Biotechnologietage We present at Deutsche Biotechnologietage 18-19 April 2018